HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Casein kinase 2 regulates both apoptosis and the cell cycle following DNA damage induced by 6-thioguanine.

AbstractPURPOSE:
The purine antimetabolite, 6-thioguanine (6-TG), is an effective drug in the management of acute leukemias. In this study, we analyze the mechanisms of apoptosis associated with 6-TG treatment and casein kinase 2 (CK2 or CKII) in human tumor cells.
EXPERIMENTAL DESIGN:
Small interfering RNA and chemical CK2 inhibitors were used to reduce CK2 activity. Control and CK2 activity-reduced cells were cultured with 6-TG and assessed by flow cytometry to measure apoptosis and cell cycle profiles. Additionally, confocal microscopy was used to assess localization of CK2 catalytic units following 6-TG treatment.
RESULTS:
Transfection of small interfering RNA against the CK2 alpha and/or alpha' catalytic subunits results in marked apoptosis of HeLa cells following treatment with 6-TG. Chemical inhibitors of CK2 also induce apoptosis following 6-TG treatment. Apoptosis induced by 6-TG is similarly observed in both mismatch repair-proficient and -deficient HCT116 and HeLa cells. Concomitant treatment with a pan-caspase inhibitor or transfection of apoptosis repressor with caspase recruitment domain markedly suppresses the apoptotic response to DNA damage by 6-TG in the CK2-reduced cells, indicating caspase regulation by CK2. CK2 alpha relocalizes to the endoplasmic reticulum after 6-TG treatment. Additionally, transfection of Cdc2 with a mutation at Ser(39) to Ala, which is the CK2 phosphorylation site, partially inhibits cell cycle progression in G(1) to G(2) phase following 6-TG treatment.
CONCLUSION:
CK2 is essential for apoptosis inhibition following DNA damage induced by 6-TG, controlling caspase activity.
AuthorsKazuhiko Yamane, Timothy J Kinsella
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 11 Issue 6 Pg. 2355-63 (Mar 15 2005) ISSN: 1078-0432 [Print] United States
PMID15788687 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Enzyme Inhibitors
  • RNA, Small Interfering
  • Casein Kinase II
  • Caspases
  • Thioguanine
Topics
  • Apoptosis (drug effects, physiology)
  • Casein Kinase II (genetics, pharmacology)
  • Caspases (drug effects, metabolism)
  • Cell Cycle (drug effects, physiology)
  • DNA Damage (drug effects)
  • DNA Repair
  • Endoplasmic Reticulum (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • HeLa Cells (enzymology)
  • Humans
  • RNA, Small Interfering (pharmacology)
  • Thioguanine (pharmacology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: